What is the sentiment of this news? Please choose an answer from {strong negative/moderately negative/mildly negative/neutral/mildly positive/moderately positive/strong positive}.

Reshma Kewalramani, Vertex Pharmaceuticals CEO, joins 'Power Lunch' to discuss the data behind a pain relieving medicine that's different from opioids, what the Phase 3 trials will look like and more.
moderately positive